Artelo Biosciences Inc (ARTL)

$1.33

Market is closed - opens 7 PM, 17 Jul 2024

Performance

  • $1.25
    $1.45
    $1.33
    downward going graph

    6.11%

    Downside

    Day's Volatility :13.88%

    Upside

    8.28%

    downward going graph
  • $1.15
    $2.98
    $1.33
    downward going graph

    13.53%

    Downside

    52 Weeks Volatility :61.41%

    Upside

    55.37%

    downward going graph

Returns

PeriodArtelo Biosciences IncIndex (Russel 2000)
3 Months
1.14%
0.0%
6 Months
-11.33%
0.0%
1 Year
-33.27%
0.0%
3 Years
-91.31%
-18.2%

Highlights

Market Capitalization
4.3M
Book Value
$2.96
Earnings Per Share (EPS)
-3.16
Wall Street Target Price
16.67
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-44.34%
Return On Equity TTM
-70.68%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-7.4M
Diluted Eps TTM
-3.16
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.82
EPS Estimate Next Year
-0.94
EPS Estimate Current Quarter
-1.05
EPS Estimate Next Quarter
-0.73

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Artelo Biosciences Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1153.38%

Current $1.33
Target $16.67

Technicals Summary

Sell

Neutral

Buy

Artelo Biosciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Artelo Biosciences Inc
Artelo Biosciences Inc
0.38%
-11.33%
-33.27%
-91.31%
-97.27%
Moderna, Inc.
Moderna, Inc.
-9.25%
24.7%
2.07%
-60.09%
791.95%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
4.75%
17.85%
51.74%
87.1%
265.7%
Novo Nordisk A/s
Novo Nordisk A/s
0.36%
32.05%
75.05%
218.96%
483.19%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.23%
12.73%
36.59%
145.42%
176.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Artelo Biosciences Inc
Artelo Biosciences Inc
NA
NA
NA
-1.82
-0.71
-0.44
NA
2.96
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.94
31.94
1.46
44.22
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
48.76
48.76
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
17.07
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Artelo Biosciences Inc
Artelo Biosciences Inc
Buy
$4.3M
-97.27%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$48.0B
791.95%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$119.2B
265.7%
31.94
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$633.1B
483.19%
48.76
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
176.04%
31.85
39.46%

Insights on Artelo Biosciences Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 75.0% return, outperforming this stock by 108.3%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 217.8% return, outperforming this stock by 308.9%

Institutional Holdings

  • Geode Capital Management, LLC

    0.61%
  • Tower Research Capital LLC

    0.15%

Company Information

artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. our programs have the potential to dramatically improve patient care in major markets. with our headquarters team in san diego, california, usa and our european office in dublin, ireland, artelo established a presence in key global biopharma innovation hubs with close access to world-class research expertise. artelo’s research and development leverages the skill, knowledge and experience of our collaboration partners in europe and north america.

Organization
Artelo Biosciences Inc
Employees
5
CEO
Mr. Gregory D. Gorgas M.B.A.
Industry
Catalog/Specialty Distribution

FAQs